The global micro guide catheter market is set for substantial expansion, with projections indicating a robust compound annual growth rate (CAGR) of 6.4% through 2034. By the end of 2024, the market is ...

The US Food and Drug Administration (FDA) has added haemodialysis bloodlines to its medical device shortages list amid supply ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...

Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in the U.S. | While ...

As of last year, this also includes the PureWick system. Generally, under DME, Part B will cover male and female external catheters with permanent urinary incontinence as an alternative to ...

In addition to the FDA 510 (k) submission, Stereotaxis expects to submit both catheters for CE mark clearance in Europe this ...

Emergen Research Logo The major Ablation Catheters market growth factors are advancements in ablation catheter technology, and minimally in ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the MAGiC Sweep™ catheter.

Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA 510(k) clearance for its Zipline™ Access Catheters. This regulatory ...

Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA ...